Abdominal adiposity, insulin resistance, and oxidized low-density lipoproteins in Latino adolescents

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Ryder, Justin R ^a   Vega López, Sonia ^a   Djedjos, Constantine S ^b   Shaibi, Gabriel Q ^a,b,c,d  

^a ARIZONA STATE UNIVERSITY   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Abdominal obesity; Insulin resistance; Latino adolescents; Metabolic syndrome; Oxidized LDL

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADOLESCENT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEMALE; GENDER; HISPANIC; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84887533052     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-72     Document Type: Article

References (20)

1. The metabolic syndrome in overweight hispanic youth and the role of insulin sensitivity. Cruz ML, Weigensberg MJ, Huang TT-K, Ball G, Shaibi GQ, Goran MI, J Clinical Endocrinol Metabol 2004 89 108 113 10.1210/jc.2003-031188 (Pubitemid 38183868)
2. Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth: A Scientific Statement from the American Heart Association. Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, et al. Circulation 2011 123 2749 2769 10.1161/CIR.0b013e31821c7c64 21555711
3. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the american heart association atherosclerosis, hypertension, and obesity in the young committee of the council on cardiovascular disease in the young; council on cardiovascular nursing; and council on nutrition, physical activity, and metabolism. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, et al. Circulation 2009 119 628 647 10.1161/CIRCULATIONAHA.108.191394 19139390
4. Autopsy studies in United States children and adolescentsa. Newman WP, Wattigney W, Berenson GS, Ann N Y Acad Sci 1991 623 16 25 10.1111/j.1749-6632. 1991.tb43715.x 2042824
5. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. May AL, Kuklina EV, Yoon PW, Pediatrics 2012 129 1035 1041 10.1542/peds.2011-1082 22614778
6. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D, Circulation 1998 98 1487 1494 10.1161/01.CIR.98.15.1487 9769301 (Pubitemid 28481664)
7. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, et al. Arterioscler Thromb Vasc Biol 2001 21 844 848 10.1161/01.ATV.21.5.844 11348884 (Pubitemid 32448777)
8. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. Diabetes 2004 53 1068 1073 10.2337/diabetes.53.4.1068 15047623 (Pubitemid 38436620)
9. Relation of circulating oxidized LDL to obesity and insulin resistance in children. Kelly AS, Jacobs DR Jr, Sinaiko AR, Moran A, Steffen LM, Steinberger J, Pediatr Diabetes 2010 11 552 555 10.1111/j.1399-5448.2009.00640.x 20102528
10. Circulating oxidized LDL and inflammation in extreme pediatric obesity. Norris AL, Steinberger J, Steffen LM, Metzig AM, Schwarzenberg SJ, Kelly AS, Obesity (Silver Spring) 2011 19 1415 1419 10.1038/oby.2011.21 21331062
11. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Mangge H, Zelzer S, Puerstner P, Schnedl WJ, Reeves G, Postolache TT, et al. Obesity (Silver Spring) 2013 21 71 E77 10.1002/oby.20061 23401248
12. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, et al. Diabetes Care 2006 29 1891 1896 10.2337/dc06-0310 16873798 (Pubitemid 44156648)
13. The Design and Conduct of a Community-Based Registry and Biorepository: A focus on Cardiometabolic Health in Latinos. In-Review. Shaibi GQ CD, Vital V, Mandarino LJ, Clin Transl Sci 2013 doi:10.1111/cts.12114. [Epub ahead of print]
14. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Matsuda M, DeFronzo RA, Diabetes Care 1999 22 1462 1470 10.2337/diacare.22.9.1462 10480510 (Pubitemid 29418240)
15. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Ceriello A, Motz E, Arterioscler Thromb Vasc Biol 2004 24 816 823 10.1161/01.ATV.0000122852.22604.78 14976002 (Pubitemid 38620857)
16. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Chait A, Brazg RL, Tribble DL, Krauss RM, Am J Med 1993 94 350 356 10.1016/0002-9343(93)90144-E 8475928 (Pubitemid 23106620)
17. The dynamics of oxidized LDL during atherogenesis. Itabe H, Obama T, Kato R, J Lipids 2011 2011 418313 21660303
18. Role of mitochondrial dysfunction in insulin resistance. Kim J-a, Wei Y, Sowers JR, Circ Res 2008 102 401 414 10.1161/CIRCRESAHA.107.165472 18309108 (Pubitemid 351651099)
19. Oxidized low-density lipoprotein and atherosclerosis. Steinberg D, Witztum JL, Arterioscler Thromb Vasc Biol 2010 30 2311 2316 10.1161/ATVBAHA.108. 179697 21084697
20. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. Van Berkel TJ, De Rijke YB, Kruijt JK, J Biol Chem 1991 266 2282 2289 1989982 (Pubitemid 21909061)